Literature DB >> 24691998

Natural IgM: beneficial autoantibodies for the control of inflammatory and autoimmune disease.

Caroline Grönwall1, Gregg J Silverman.   

Abstract

Natural IgM are highly represented in the circulation at birth, and these often autoreactive antibodies have been postulated to have innate-like properties and play crucial roles in apoptotic cell clearance, tissue homeostasis, and immune modulation. This review summarizes the known properties of these IgM autoantibodies, and the evidence that these anti-apoptotic cell IgM natural antibodies can regulate inflammatory responses through ancient pathways of the innate immune system that first arose long before the initial emergence of the adaptive immune system. While the regulatory contributions of these natural IgM autoantibodies are certainly not an essential and fundamental component of host defenses, these provide an additional layer to further protect the host. More importantly, these IgM antibody responses are highly inducible and their up-regulation can be a powerful means for the host to survive in a setting of chronic inflammation. The observed beneficial clinical associations for cardiovascular disease and autoimmunity, as well as opportunities for potential therapeutic implications are discussed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24691998      PMCID: PMC4354681          DOI: 10.1007/s10875-014-0025-4

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  128 in total

Review 1.  Intravenous immunoglobulin: exploiting the potential of natural antibodies.

Authors:  Srini V Kaveri
Journal:  Autoimmun Rev       Date:  2012-02-12       Impact factor: 9.754

2.  IgM-phosphorylcholine autoantibodies and outcome in acute coronary syndromes.

Authors:  Kenneth Caidahl; Marianne Hartford; Thomas Karlsson; Johan Herlitz; Knut Pettersson; Ulf de Faire; Johan Frostegård
Journal:  Int J Cardiol       Date:  2012-02-04       Impact factor: 4.164

3.  Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension.

Authors:  Jun Su; Anastasia Georgiades; Ruihua Wu; Thomas Thulin; Ulf de Faire; Johan Frostegård
Journal:  Atherosclerosis       Date:  2005-11-22       Impact factor: 5.162

Review 4.  CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire.

Authors:  P Casali; A L Notkins
Journal:  Immunol Today       Date:  1989-11

5.  A single VH gene is utilized predominantly in anti-BrMRBC hybridomas derived from purified Ly-1 B cells. Definition of the VH11 family.

Authors:  R R Hardy; C E Carmack; S A Shinton; R J Riblet; K Hayakawa
Journal:  J Immunol       Date:  1989-05-15       Impact factor: 5.422

6.  Developmentally controlled expression of immunoglobulin VH genes.

Authors:  R M Perlmutter; J F Kearney; S P Chang; L E Hood
Journal:  Science       Date:  1985-03-29       Impact factor: 47.728

7.  High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus.

Authors:  A Perniok; F Wedekind; M Herrmann; C Specker; M Schneider
Journal:  Lupus       Date:  1998       Impact factor: 2.911

8.  Molecular basis of 9G4 B cell autoreactivity in human systemic lupus erythematosus.

Authors:  Christopher Richardson; Asiya Seema Chida; Diana Adlowitz; Lin Silver; Erin Fox; Scott A Jenks; Elise Palmer; Youliang Wang; Jamie Heimburg-Molinaro; Quan-Zhen Li; Chandra Mohan; Richard Cummings; Christopher Tipton; Ignacio Sanz
Journal:  J Immunol       Date:  2013-10-09       Impact factor: 5.422

Review 9.  Positive selection focuses the VH12 B-cell repertoire towards a single B1 specificity with survival function.

Authors:  Hongsheng Wang; Stephen H Clarke
Journal:  Immunol Rev       Date:  2004-02       Impact factor: 12.988

10.  Restricted immunoglobulin variable region gene usage by normal Ly-1 (CD5+) B cells that recognize phosphatidyl choline.

Authors:  T J Mercolino; A L Locke; A Afshari; D Sasser; W W Travis; L W Arnold; G Haughton
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

View more
  59 in total

1.  Autoimmunity: Do IgM antibodies protect against atherosclerosis in SLE?

Authors:  Maureen McMahon; Brian Skaggs
Journal:  Nat Rev Rheumatol       Date:  2016-06-30       Impact factor: 20.543

2.  IgM ANCA in healthy individuals and in patients with ANCA-associated vasculitis.

Authors:  L S Jeffs; C A Peh; A Nelson; P G Tan; E Davey; K Chappell; G B Perkins; P R Hurtado
Journal:  Immunol Res       Date:  2019-10       Impact factor: 2.829

3.  IgM Plasma Cells Reside in Healthy Skin and Accumulate with Chronic Inflammation.

Authors:  R Paul Wilson; Shannon E McGettigan; Van Duc Dang; Anil Kumar; Michael P Cancro; Neda Nikbakht; William Stohl; Gudrun F Debes
Journal:  J Invest Dermatol       Date:  2019-05-30       Impact factor: 8.551

4.  Immune Surveillance by Natural IgM Is Required for Early Neoantigen Recognition and Initiation of Adaptive Immunity.

Authors:  Shaikh M Atif; Sophie L Gibbings; Elizabeth F Redente; Faye A Camp; Raul M Torres; Ross M Kedl; Peter M Henson; Claudia V Jakubzick
Journal:  Am J Respir Cell Mol Biol       Date:  2018-11       Impact factor: 6.914

Review 5.  A Special Connection between γδ T Cells and Natural Antibodies?

Authors:  Willi K Born; Yafei Huang; Wanjiang Zeng; Raul M Torres; Rebecca L O'Brien
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2016-05-27       Impact factor: 4.291

6.  Correlation of natural autoantibodies and cardiovascular disease-related anti-bacterial antibodies in pericardial fluid of cardiac surgery patients.

Authors:  D Simon; O Gilicze; N Farkas; J Najbauer; P Németh; L Lénárd; T Berki
Journal:  Clin Exp Immunol       Date:  2018-07       Impact factor: 4.330

7.  Characterization of a natural mouse monoclonal antibody recognizing epitopes shared by oxidized low-density lipoprotein and chaperonin 60 of Aggregatibacter actinomycetemcomitans.

Authors:  Chunguang Wang; Jari Kankaanpää; Outi Kummu; S Pauliina Turunen; Ramin Akhi; Ulrich Bergmann; Pirkko Pussinen; Anne M Remes; Sohvi Hörkkö
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

Review 8.  Manipulation of the glycan-specific natural antibody repertoire for immunotherapy.

Authors:  J Stewart New; R Glenn King; John F Kearney
Journal:  Immunol Rev       Date:  2016-03       Impact factor: 12.988

9.  FcμR in human B cell subsets in primary selective IgM deficiency, and regulation of FcμR and production of natural IgM antibodies by IGIV.

Authors:  Sudhir Gupta; Sudhanshu Agrawal; Sastry Gollapudi; Hiromi Kubagawa
Journal:  Hum Immunol       Date:  2016-10-14       Impact factor: 2.850

Review 10.  Drivers and regulators of humoral innate immune responses to infection and cancer.

Authors:  Deepak Kumar; Yeni Romero; Kaitlynn N Schuck; Haley Smalley; Bibek Subedi; Sherry D Fleming
Journal:  Mol Immunol       Date:  2020-03-18       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.